Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of <scp><i>KRAS</i></scp> status
Junko Kato(Tokai University), Kazuhiro Yoshida(Kyoto Institute of Technology)
Cited by 17
Related Papers
Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
|Oncology Reports|2021|26
Possible role of p53/Mieap‐regulated mitochondrial quality control as a tumor suppressor in human breast cancer
|Cancer Science|2018|24